Biomolecules (Sep 2021)

The Combined Use of Platelet-Rich Plasma and Adipose-Derived Mesenchymal Stem Cells Promotes Healing. A Review of Experimental Models and Future Perspectives

  • Dimitris Tatsis,
  • Varvara Vasalou,
  • Efstathios Kotidis,
  • Elissavet Anestiadou,
  • Ioannis Grivas,
  • Angeliki Cheva,
  • Georgios Koliakos,
  • Gregory Venetis,
  • Manousos-George Pramateftakis,
  • Nikolaos Ouzounidis,
  • Stamatis Angelopoulos

DOI
https://doi.org/10.3390/biom11101403
Journal volume & issue
Vol. 11, no. 10
p. 1403

Abstract

Read online

Wound healing and tissue regeneration are a field of clinical medicine presenting high research interest, since various local and systematic factors can inhibit these processes and lead to an inferior result. New methods of healing enhancement constantly arise, which, however, require experimental validation before their establishment in everyday practice. Platelet-rich plasma (PRP) is a well-known autologous factor that promotes tissue healing in various surgical defects. PRP derives from the centrifugation of peripheral blood and has a high concentration of growth factors that promote healing. Recently, the use of adipose-derived mesenchymal stem cells (ADMSCs) has been thoroughly investigated as a form of wound healing enhancement. ADMSCs are autologous stem cells deriving from fat tissue, with a capability of differentiation in specific cells, depending on the micro-environment that they are exposed to. The aim of the present comprehensive review is to record the experimental studies that have been published and investigate the synergistic use of PRP and ADMSC in animal models. The technical aspects of experimentations, as well as the major results of each study, are discussed. In addition, the limited clinical studies including humans are also reported. Future perspectives are discussed, along with the limitations of current studies on the long-term follow up needed on efficacy and safety.

Keywords